Clinical Trial Update: Efficacy of Iodopovidone Versus Talc in Palliative Malignant Pleural Effusion [Phase 3]

View source ↗

Summary

Phase 3 trial comparing iodopovidone to talc for palliation in malignant pleural effusion has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Malignant Pleural Effusion

Drugs mentioned

• Iodopovidone (povidone-iodine)
• Talc (talc)

Snippet

Sponsor: Chiang Mai University | Conditions: Malignant Pleural Effusion | Phase 3 | Status: COMPLETED